Page last updated: 2024-11-05

ethyl myristate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ethyl myristate is an ester formed from the reaction of myristic acid and ethanol. It is a colorless, odorless liquid that is found naturally in some plants and animals. It is used as a solvent, plasticizer, and emollient in cosmetics and pharmaceuticals. Its properties make it useful as a skin-conditioning agent, helping to maintain moisture and improve skin texture. It is also studied for its potential use in treating skin conditions such as eczema and psoriasis. '

ethyl myristate : A long-chain fatty acid ethyl ester resulting from the formal condensation of the carboxy group of myristic acid with the hydroxy group of ethanol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID31283
CHEMBL ID207555
CHEBI ID84849
SCHEMBL ID116495
MeSH IDM0101136

Synonyms (59)

Synonym
AKOS015839783
ethyl myristate (natural)
fema no. 2445
ai3-01024
einecs 204-675-4
nsc 8917
ethyl myristate
nsc8917
ethyl tetradecanoate
tetradecanoic acid, ethyl ester
nsc-8917
124-06-1
myristic acid, ethyl ester
ethyl myristate, 99% (gc)
ethyl myristate, >=98%, fcc, fg
myristic acid ethyl ester
chebi:84849 ,
CHEMBL207555
QSPL 070
M0479
A805193
QSPL 039
QSPL 164
LMFA07010468
we(2:0/14:0)
tox21_303520
dtxcid4027654
NCGC00257436-01
dtxsid6047654 ,
cas-124-06-1
unii-6995s49749
6995s49749 ,
FT-0626238
ethyl myristate [fcc]
ethyl myristate [inci]
ethyl myristate [fhfi]
myristic acid ethyl ester [mi]
ethylmyristate
SCHEMBL116495
ethyl ester tetradecanoic acid
ethyl n-tetradecanoate
ethyl ester of tetradecanoic acid
HMS3650O07
mfcd00008984
J-005039
ethyl myristate, analytical standard
ethyl myristate, natural, 98%, fg
tetradecanoic acid-ethyl ester
ethyl tetradecanoate (ethyl myristate)
fema 2445
myristic acid, ethyl ester (8ci)
SY033131
ethyl-myristate
DS-6368
Q27158117
SR-01000946816-1
sr-01000946816
AC8510
tetradecanoic acid ethyl ester

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
long-chain fatty acid ethyl esterA fatty acid ethyl ester resulting from the formal condensation of the carboxy group of a long-chain fatty acid with the hydroxy group of ethanol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency76.95880.006038.004119,952.5996AID1159521
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency0.24340.000627.21521,122.0200AID743202
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1659751Agonist activity at TRPA1 (unknown origin) at 1000 uM relative to AITC2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Identification of a new class of non-electrophilic TRPA1 agonists by a structure-based virtual screening approach.
AID264978Antibacterial activity against Escherichia coli2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives.
AID264976Antibacterial activity against Staphylococcus aureus2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives.
AID264977Antibacterial activity against Micrococcus luteus2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.14)18.7374
1990's0 (0.00)18.2507
2000's7 (50.00)29.6817
2010's4 (28.57)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.61 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index43.69 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]